[1]
Zhang, S. 2026. Aducanumab and Lecanemab: Target Specificity, Mechanisms and Clinical Outcomes in Alzheimer’s Disease. MedScien. 4, 4 (Aug. 2026), 7302. DOI:https://doi.org/10.61173/yhcven77.